NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 1 to 25 of 1426

Display Results as:

The Impact of Microenvironment on Lung Progenitor Cell Function (R01) - RFA-HL-18-022

Organization: NHLBI 

Posting Date: 06-14-2017 

Expiration Date: 01-17-2018 

Activity Code: R01 

Summary: This Funding Opportunity Announcement (FOA) invites applications for basic research to elucidate the impact of microenvironment, which includes cellular components of the niche, extracellular matrix, and soluble factors, on lung progenitor cell phenotype and function during development, homeostasis, repair and regeneration. Multi-disciplinary teams with complementary expertise are encouraged to propose innovative, hypothesis-based studies to catalyze this understudied area critical to advancing lung stem cell biology. This FOA will also support the development of novel 3-dimensional, multi-component models to interrogate lung stem cell niches.  

Cardiovascular and Pulmonary Research on E-Cigarettes (R01) - RFA-HL-18-024

Organization: NHLBI 

Posting Date: 08-01-2017 

Expiration Date: 01-17-2018 

Activity Code: R01 

Summary: The purpose of this funding opportunity announcement (FOA) is to stimulate research on cardiovascular and pulmonary physiologic and health effects of electronic cigarette (e-cigarette) exposure. This FOA invites applications addressing the effects of e-cigarettes on the cardiovascular and pulmonary systems, alone or in combination. Studies involving clinical populations, animal models and/or cell preparations would all be considered responsive. Research may examine the effects of the whole e-cigarette aerosol or of individual components or constituents. Research may also examine where aerosols, components, or constituents deposit in the airways and resulting heart and/or lung consequences. 

Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54) - RFA-NS-18-001

Organization: NINDS 

Posting Date: 09-07-2017 

Expiration Date: 01-17-2018 

Activity Code: U54 

Summary: The purpose of this Funding Opportunity Announcement (FOA) is to encourage cooperative agreement (U54) applications from multidisciplinary groups of investigators to accelerate the rate of progress in determining the functional, pharmacological, neuronal network and whole animal consequences of genetic variants discovered in patients with various types of epilepsy and to develop strategies for establishing diagnostic criteria and identifying potential targets for intervention. 

Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01) - RFA-CA-17-045

Organization: NCI 

Posting Date: 10-10-2017 

Expiration Date: 01-17-2018 

Activity Code: U01 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.  

Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24) - RFA-CA-17-048

Organization: NCI 

Posting Date: 10-10-2017 

Expiration Date: 01-17-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.  

Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24) - RFA-CA-17-047

Organization: NCI 

Posting Date: 10-10-2017 

Expiration Date: 01-17-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur. 

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01) - RFA-CA-17-046

Organization: NCI 

Posting Date: 10-10-2017 

Expiration Date: 01-17-2018 

Activity Code: U01 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.  

Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01) - RFA-CA-17-052

Organization: NCI 

Posting Date: 09-25-2017 

Expiration Date: 01-18-2018 

Activity Code: U01 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer Moonshot InitiativeSM that is intended to accelerate cancer research. The purpose of this FOA is to promote research on developing the descriptive, inferential, and graphical statistical methods for data generated in clinical trials including Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) items. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Accelerate research that can identify approaches to monitor and manage patient-reported symptoms.  

Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1) - RFA-CA-17-042

Organization: NCI 

Posting Date: 10-18-2017 

Expiration Date: 01-18-2018 

Activity Code: UM1 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of integrated symptom monitoring and management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship. 

Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24) - RFA-CA-17-043

Organization: NCI 

Posting Date: 10-18-2017 

Expiration Date: 01-18-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative established to accelerate cancer research. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): the Implementation of Integrated and Evidenced-based Symptom Management Throughout the Cancer Trajectory. The purpose of this specific FOA is to promote research on the implementation and evaluation of comprehensive symptom management systems for use in cancer care delivery through a Research Consortium. This research will provide new insights and valuable evidence that can be used to guide efforts on a nation-wide basis to improve symptom control for cancer patients during treatment and survivorship. 

NCI Research Specialist (Laboratory-based Scientist) Award (R50) - PAR-18-341

Organization: NCI 

Posting Date: 11-02-2017 

Expiration Date: 01-18-2018 

Activity Code: R50 

Summary: This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists. 

NCI Research Specialist (Core-based Scientist) Award (R50) - PAR-18-342

Organization: NCI 

Posting Date: 11-02-2017 

Expiration Date: 01-18-2018 

Activity Code: R50 

Summary: This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. 

Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54) - RFA-CA-17-032

Organization: NCI 

Posting Date: 10-13-2017 

Expiration Date: 01-19-2018 

Activity Code: U54 

Summary: This funding opportunity announcement (FOA) solicits applications for Minority PDX (minority patient-derived xenografts) Development and Trial Centers (M-PDTCs). The M-PDTCs will join the PDTC Research Network (PDXNet) and be focused upon development and pre-clinical testing of models derived from racial/ethnic minority populations. The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale model development and pre-clinical testing of targeted therapeutic agents to advance the vision of cancer precision medicine. 

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20) - RFA-CA-17-033

Organization: NCI 

Posting Date: 10-13-2017 

Expiration Date: 01-19-2018 

Activity Code: P20 

Summary: This Funding Opportunity Announcement (FOA) invites applications for development of translational research programs that are focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs. It is the expectation that the research programs developed by the P20 awards should be competitive with other applications for a full Specialized Programs of Research Excellence (SPORE), addressing cancer health disparities as a cross-cutting research theme. 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3) - RFA-CA-17-038

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: UG3/UH3 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. This purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based approaches. 

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24) - RFA-CA-17-039

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research in colorectal cancer screening, follow-up, and referral-to-care among target populations for whom screening rates are below national standards. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Prevention and Screening: Implementation of Evidence-based Approaches. 

Human Tumor Atlases (HTA) Precancer Atlas Research Centers (U2C) - RFA-CA-17-035

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U2C 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic, multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases. 

Human Tumor Atlases (HTA) Research Centers (U2C) - RFA-CA-17-034

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U2C 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic multidimensional tumor ecosystem. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases. 

Human Tumor Atlas Network: Data Coordinating Center (U24) - RFA-CA-17-036

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-19-2018 

Activity Code: U24 

Summary: This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to promote research that results in a comprehensive view of the dynamic multidimensional tumor ecosystem. Specifically, this FOA targets the following area(s) designated as a scientific priority by the Blue Ribbon Panel (BRP): Generation of Human Tumor Atlases. 

Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33) - RFA-AT-18-002

Organization: NCCIH  (formerly NCCAM)

Posting Date: 11-16-2017 

Expiration Date: 01-19-2018 

Activity Code: R21/R33 

Summary: The purpose of this FOA is to solicit applications to examine the impact of behavioral interventions within the context of states plans for use of the SAMHSA Opioid STR grant funds authorized under the 21st Century Cures Act. Applications are encouraged for studies that examine the impact of interventions such as mindfulness meditation, cognitive behavioral therapy, or multi-disciplinary rehabilitation for primary or secondary prevention for opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) of OUD. Applications that emphasize treatment of the comorbidity of OUD and chronic pain are of particular interest. 

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01) - RFA-NS-18-010

Organization: NINDS 

Posting Date: 10-05-2017 

Expiration Date: 01-20-2018 

Activity Code: U01 

Summary: Invasive surgical procedures provide the unique ability to record and stimulate neurons within precisely localized brain structures in humans. Human studies using invasive technology are often constrained by a limited number of patients and resources available to implement complex experimental protocols and are rarely aggregated in a manner that addresses research questions with appropriate statistical power. Therefore, this FOA seeks applications to assemble integrated, multi-disciplinary teams to overcome these fundamental barriers. Projects should investigate high-impact questions in human neuroscience. The research should be offered as exploratory research and planning activities to establish feasibility, proof-of-principle and early-stage development that will later compete for continued funding under new or ongoing FOAs of the BRAIN Initiative or under NIH Institute appropriations. Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to brain recording and stimulating from invasive surgical procedures. In addition, projects that aim to implement novel methods of temporally-linked brain-behavior quantification in laboratory and real-world settings are encouraged. Awardees will join a consortium work group, coordinated by the NIH, to identify consensus standards of practice as well as supplemental opportunities to collect and provide data for ancillary studies, and to aggregate and standardize data for dissemination among the wider scientific community. 

Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10) - RFA-CA-17-056

Organization: NCI 

Posting Date: 10-19-2017 

Expiration Date: 01-20-2018 

Activity Code: U10 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain a Network Group Operations Center for the NCI National Clinical Trials Network (NCTN). The NCTN Network Group Operations Centers will provide scientific leadership for developing and implementing multi-disciplinary, multi-institutional trials in a range of cancer types and special populations with specific scientific strategy and goals. 

Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10) - RFA-CA-17-057

Organization: NCI 

Posting Date: 10-19-2017 

Expiration Date: 01-20-2018 

Activity Code: U10 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain Network Group Statistics and Data Management Centers (SDMCs) for the NCI National Clinical Trials Network (NCTN). The NCTN Network SDMCs will provide statistical expertise for effective scientific design, conduct, and data management of clinical trials led by the associated NCTN Network Group Operations Center. 

Limited Competition: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10) - RFA-CA-17-058

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-20-2018 

Activity Code: U10 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain a Canadian Collaborating Clinical Trials Network for the NCI National Clinical Trials Network (NCTN). The NCTN Canadian Collaborating Clinical Trials Network will be a full partner with the U.S. Network in the conduct of large-scale, multi-site clinical trials and help provide regulatory expertise/oversight for the conduct of NCTN trials in Canada. The competition for an award under this FOA is limited to eligible Canadian institutions. 

NCI National Clinical Trials Network (NCTN)--Network Lead Academic Participating Sites (UG1) - RFA-CA-17-059

Organization: NCI 

Posting Date: 10-20-2017 

Expiration Date: 01-20-2018 

Activity Code: UG1 

Summary: The purpose of this funding opportunity announcement (FOA) is to solicit applications from institutions/organizations that propose to maintain or establish Network Lead Academic Participating Sites (LAPS) for the NCI National Clinical Trials Network (NCTN). The NCTN Network LAPS will provide scientific leadership by helping to develop and conduct clinical trials in association with one or more adult Network Groups and will contribute substantial accrual to clinical trials conducted across the entire NCTN. 

Current Search

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

ORD

ORI

ORIP

ORWH

OSC

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top